35th PARLIAMENT, 2nd SESSION
EVIDENCE
on
INDUSTRY
ORDER OF THE DAY:
Review of Section 14 of the Patent Act Amendment 1992 (Chapter 2, Statutes of Canada, 1993)
WITNESSES:
Board of Trade of Metropolitan Toronto:
David McFadden, Vice-President.
Canadian Pharmaceutical Association:
Garry Cruickshank, Vice-President;
Noëlle-Dominique Willems, Director of Government and Public Affairs.
Chamber of Commerce of Montreal:
Luc Lacharité, Executive Vice-President.
Grey Clark Shih and Associates:
Peter Clark, President.
Groupement provincial de l'industrie du médicament:
Pierre Morin.
Map International of Canada:
John P. Kelsall, President;
Robert Stephens, Member.
Novopharm Limited:
David Howard, President, Stanley Pharmaceuticals Ltd.;
Jacques Messier, President and Chief Operating Officer;
David Windross, Director, Government and Professional Affairs.
New Democratic Party:
Alexa McDonough, Leader;
Stephen Shrybman, Policy Analyst.
Quebec Research Group on Medication Use on the Elderly:
Robyn Tamblyn.
University of British Columbia:
James Wright, Department of Pharmacology and Therapeutics.